Sumatriptan Spray
Product Images NDC 71921-170

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 71921-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Chemical Structure (Sumatriptan Nasalspray Spl Graphic 01)

Chemical structure of sumatriptan, the active ingredient in Sumatriptan 20 mg nasal spray by Florida Pharmaceutical Products, LLC. The diagram depicts the molecular structure with labeled chemical groups and bonds.*

FDA Label Image

Figure 1. Estimated Probability Of Initial Headache Response Within 120 Minutes (Sumatriptan Nasalspray Spl Graphic 02)

A line graph showing the estimated probability of response over time in minutes from the initial dose for sumatriptan nasal spray at doses of 5 mg, 10 mg, 20 mg, and placebo. The graph indicates that higher doses correspond to higher response probabilities over a 120-minute period.*

FDA Label Image

Figure 2. Probability Of Patients Needing Second Dose Or Additional Medication (Sumatriptan Nasalspray Spl Graphic 03)

A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose, comparing placebo, 5 mg, 10 mg, and 20 mg doses of sumatriptan nasal spray. The curves illustrate increasing probabilities over time for each dose, with placebo lowest, followed by 5 mg, 10 mg, and highest for 20 mg dose.*

FDA Label Image

Figure A (Sumatriptan Nasalspray Spl Graphic 04)

An image showing a person's hands opening a foil pouch. The pouch appears to be single-use packaging, likely for a pharmaceutical nasal spray product such as Sumatriptan nasal spray 20 mg/1 spray. The background is plain blue, focusing on the action of opening the pouch.*

FDA Label Image

Figure B (Sumatriptan Nasalspray Spl Graphic 05)

FDA Label Image

Figure C (Sumatriptan Nasalspray Spl Graphic 06)

An instructional illustration showing a man demonstrating nasal spray administration. He is holding his nose with one hand, presumably to close one nostril, while preparing to use a nasal spray with the other hand. The background is plain blue.*

FDA Label Image

Figure D (Sumatriptan Nasalspray Spl Graphic 07)

An instructional illustration showing a hand holding a nasal spray applicator component labeled with 'Nozzle' and 'Plunger.' The image highlights these parts of the spray device, relevant for Sumatriptan nasal spray usage.*

FDA Label Image

Figure E (Sumatriptan Nasalspray Spl Graphic 08)

An instructional photograph demonstrating the proper use of a nasal spray. A person holds the spray applicator inserted into one nostril while using the opposite hand's finger to gently close the other nostril, illustrating correct administration technique for nasal spray delivery.*

FDA Label Image

Figure F (Sumatriptan Nasalspray Spl Graphic 09)

Illustration showing a man demonstrating the use of a nasal spray. The man is holding the spray device near his nose, positioned to administer the medication through the nasal route.*

FDA Label Image

Imitrex Nasal 20 mg 6 Count Carton (Sumatriptan Nasalspray Spl Graphic 10)

Label layout for Sumatriptan Nasal Spray, USP 20 mg by Florida Pharmaceutical Products, LLC. The label shows the product name, strength (20 mg), dosage form as nasal spray, and package content of 6 nasal spray units. It includes directions for intranasal use, manufacturer details, storage instructions, inactive ingredients, and the NDC 71921-170-61.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.